PharVision Advisers’s FormFactor FORM Stock Holding History

PharVision Advisers’s Portfolio FORM Stock Details FORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,701	Closed	-$206K	–	311
2025 Q4	$206K	Buy	+3,701	New	+$186K	0.1%	533

Other funds holding FORM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

PharVision Advisers's FORM Position: Q1 2026 in Review

PharVision Advisers sold out of FormFactor (FORM) in Q1 2026, closing a stake of 3,701 shares — an estimated $206K sold.

PharVision Advisers first reported a position in FORM in Q4 2025 and held it in 1 quarter. The position peaked at $206K in Q4 2025. 393 funds tracked by Wall St. Rank hold FORM as of Q1 2026.

PharVision Advisers reported no remaining FormFactor position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 3,701 FormFactor shares in Q1 2026, an estimated $206K.
PharVision Advisers first reported a position in FormFactor in Q4 2025 and held it in 1 quarter.
PharVision Advisers's FormFactor position peaked at $206K in Q4 2025.
393 funds tracked by Wall St. Rank held FormFactor as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.